Connection

JOYA CHANDRA to Adamantane

This is a "connection" page, showing publications JOYA CHANDRA has written about Adamantane.
Connection Strength

1.573
  1. Combinatorial effects of histone deacetylase inhibitors (HDACi), vorinostat and entinostat, and adaphostin are characterized by distinct redox alterations. Cancer Chemother Pharmacol. 2018 03; 81(3):483-495.
    View in: PubMed
    Score: 0.609
  2. Adaphostin cytoxicity in glioblastoma cells is ROS-dependent and is accompanied by upregulation of heme oxygenase-1. Cancer Chemother Pharmacol. 2007 Mar; 59(4):527-35.
    View in: PubMed
    Score: 0.276
  3. Adaphostin-induced oxidative stress overcomes BCR/ABL mutation-dependent and -independent imatinib resistance. Blood. 2006 Mar 15; 107(6):2501-6.
    View in: PubMed
    Score: 0.262
  4. Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells. Blood. 2003 Dec 15; 102(13):4512-9.
    View in: PubMed
    Score: 0.224
  5. Oxidative stress by targeted agents promotes cytotoxicity in hematologic malignancies. Antioxid Redox Signal. 2009 May; 11(5):1123-37.
    View in: PubMed
    Score: 0.083
  6. Adaphostin has significant and selective activity against chronic and acute myeloid leukemia cells. Cancer Sci. 2006 Sep; 97(9):952-60.
    View in: PubMed
    Score: 0.068
  7. Effects of the Bcr/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in vitro. Blood. 2002 Jan 15; 99(2):664-71.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.